| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-15 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.26 | 5e-14 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.26 | 9e-14 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-12 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-11 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-11 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-10 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-10 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-09 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-09 |